RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Towards rational design of cannabinoid receptor 1 (CB1) antagonists for peripheral selectivity
Fulp, A., Bortoff, K., Zhang, Y., Seltzman, H., Snyder, R., & Maitra, R. (2011). Towards rational design of cannabinoid receptor 1 (CB1) antagonists for peripheral selectivity. Bioorganic and Medicinal Chemistry Letters, 21(19), 5711-5714.
CB1 receptor antagonists that are peripherally restricted were targeted. Compounds with permanent charge as well as compounds that have increased polar surface area were made and tested against CB1 for binding and activity. Sulfonamide and sulfamide with high polar surface area and good activity at CB1 were rationally designed and pharmacologically tested. Further optimization of these compounds and testing could lead to the development of a new class of therapeutics to treat disorders where the CB1 receptor system has been implicated. (C) 2011 Elsevier Ltd. All rights reserved
